KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenet Healthcare (THC) Amortization of Deferred Charges (2016 - 2025)

Historic Amortization of Deferred Charges for Tenet Healthcare (THC) over the last 16 years, with Q4 2025 value amounting to $5.0 million.

  • Tenet Healthcare's Amortization of Deferred Charges changed 0.0% to $5.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $23.0 million, marking a year-over-year decrease of 1153.85%. This contributed to the annual value of $23.0 million for FY2025, which is 1153.85% down from last year.
  • As of Q4 2025, Tenet Healthcare's Amortization of Deferred Charges stood at $5.0 million, which was down 0.0% from $6.0 million recorded in Q3 2025.
  • In the past 5 years, Tenet Healthcare's Amortization of Deferred Charges registered a high of $10.0 million during Q4 2022, and its lowest value of $5.0 million during Q4 2024.
  • Moreover, its 5-year median value for Amortization of Deferred Charges was $7.5 million (2021), whereas its average is $7.4 million.
  • In the last 5 years, Tenet Healthcare's Amortization of Deferred Charges soared by 2857.14% in 2023 and then tumbled by 3333.33% in 2024.
  • Over the past 5 years, Tenet Healthcare's Amortization of Deferred Charges (Quarter) stood at $8.0 million in 2021, then increased by 25.0% to $10.0 million in 2022, then dropped by 30.0% to $7.0 million in 2023, then fell by 28.57% to $5.0 million in 2024, then changed by 0.0% to $5.0 million in 2025.
  • Its Amortization of Deferred Charges stands at $5.0 million for Q4 2025, versus $6.0 million for Q3 2025 and $6.0 million for Q2 2025.